Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Parliamentary no vote sounds death knell for ACTA

This article was originally published in SRA

Executive Summary

The European Parliament's International Trade Committee has dealt a decisive blow to the controversial Anti-Counterfeiting Trade Agreement (ACTA), which aims to tackle international intellectual property rights violations1,2. As had been expected, members of the European Parliament have voted to reject the treaty, making it even more unlikely that that the agreement will be ratified in the EU.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS116849

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel